|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
14
|
Sun, 7/29/07, 2:00 PM - 3:50 PM | CC-255 D |
| Efficient Designs in Drug Development - Topic Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section, ENAR |
||
| Organizer(s): Michael Smith, Pfizer Inc. | ||
| Chair(s): Scott Patterson, GlaxoSmithKline | ||
| 2:05 PM |
Bayesian Forecasting of Multicenter Enrollment —  Byron Jones, Pfizer Inc.
|
|
| 2:25 PM |
A Bayesian Design and Analysis for Dose-Response Using Informative Prior Information — Michael Smith, Pfizer Inc.; Scott Marshall, Pfizer Inc.
|
|
| 2:45 PM |
Optimizing the Manufacturing of Phase III Material During Phase II Trials — Nitin Patel, Cytel Inc.; Francoise Vandenhende, Eli Lilly and Company
|
|
| 3:05 PM |
Accounting for Patient Heterogeneity in Phase II Clinical Trials — J. Kyle Wathen, The University of Texas M.D. Anderson Cancer Center; Peter F. Thall, The University of Texas M.D. Anderson Cancer Center; John D. Cook, The University of Texas M.D. Anderson Cancer Center
|
|
| 3:25 PM | Floor Discussion | |
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |